Cryotherapy versus salicylic acid for the treatment of verrucae
- Conditions
- Viral wartsVerrucae (plantar warts)Infections and Infestations
- Registration Number
- ISRCTN18994246
- Lead Sponsor
- niversity of York (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 266
1. Patients aged 12 years and over
2. With a verruca that in the opinion of the health care professional is suitable for treatment with either salicylic acid or cryotherapy
1. Patients are currently in a trial evaluating other treatments for their verruca
2. They have impaired healing e.g. due to diabetes, peripheral vascular disease or any other condition which means the patient has impaired healing
3. They are immunosuppressed, e.g. have agammaglobulinaemia, or are currently taking immunosuppressant drugs such as corticosteroids
4. They are unable to give informed consent
5. They are currently on renal dialysis
6. They have cold intolerance e.g. Raynaud's syndrome or cold urticaria
7. They have any of the following conditions: blood dyscrasias of unknown origin, cryoglobulinaemia, cryofibrinogenaemia, collagen and auto-immune disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete clearance of all verrucae as observed on digital photographs taken at baseline and 12 weeks and assessed by an independent health care professional.
- Secondary Outcome Measures
Name Time Method 1. Self-reported clearance of verrucae at 6 months<br>2. Self-reported time to clearance of verrucae<br>3. Data will also be collected on side effects of treatment, pain intensity after treatment, use of painkillers, restrictions to lifestyle due to having verrucae, treatment details and patient satisfaction with treatment.